feed,title,long_url,short_url
MarketWatch,Sarepta stock plunges more than 50% after mixed results from drug study,http://www.marketwatch.com/news/story.asp?guid=%7B21005575-02D4-D4B5-4572-D1E02CD0AA58%7D&siteid=rss&rss=1,https://on.mktw.net/2LsZegn
